Implantation and preliminary follow-up of the Bard Valeo stent in pulmonary artery stenosis

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 2, 2014, Pages 197-203

  Kudumula, Vikram ^a   Noonan, Patrick ^b   Taliotis, Demetris ^a   Duke, Christopher ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

congenital heart disease; pediatric intervention; pediatrics; stent design structure coatings; stent, bare metal; structural heart disease intervention

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FLUOROSCOPY; HEMODYNAMICS; HUMAN; PRESSURE GRADIENT; PULMONARY ARTERY STENOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; VASCULAR STENT; ADOLESCENT; ADVERSE EFFECTS; ARTERIAL OCCLUSIVE DISEASES; ARTERIAL PRESSURE; DEVICES; INFANT; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESCHOOL CHILD; PROSTHESIS; PULMONARY ARTERY; RADIOGRAPHY; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TIME; TREATMENT OUTCOME; VASCULAR PATENCY; YOUNG ADULT;

ADOLESCENT; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; ARTERIAL PRESSURE; CHILD; CHILD, PRESCHOOL; CONSTRICTION, PATHOLOGIC; HUMANS; INFANT; PROSTHESIS DESIGN; PULMONARY ARTERY; RETROSPECTIVE STUDIES; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; YOUNG ADULT;

EID: 84904463954     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25443     Document Type: Article

References (16)

1. O'Laughlin MP, Perry SB, Lock JE, Mullins CE,. Use of endovascular stents in congenital heart disease. Circulation 1991; 83: 1923-1939.
2. Peuster M, Wohlsein P, Brugmann M, Ehlerding M, Seidler K, Fink C, Brauer H, Fischer A, Hausdorf G,. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart 2001; 86: 563-569.
3. Zartner P, Cesnjevar R, Singer H, Weyand M,. First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby. Catheter Cardiovasc Interv 2005; 66: 590-594.
4. McMahon CJ, Oslizlok P, Walsh KP,. Early restenosis following biodegradable stent implantation in an aortopulmonary collateral of a patient with pulmonary atresia and hypoplastic pulmonary arteries. Catheter Cardiovasc Interv 2007; 69: 735-738.
5. Schranz D, Zartner P, Michel-Behnke I, Akinturk H,. Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newborn. Catheter Cardiovasc Interv 2006; 67: 671-673.
6. Reddy SR, Welch TR, Wang J, Bernstein F, Richardson JA, Forbess JM, Nugent AW,. A novel biodegradable stent applicable for use in congenital heart disease: Bench testing and feasibility results in a rabbit model. Catheter Cardiovasc Interv 2014; 83: 448-456.
7. Duke C, Rosenthal E, Qureshi SA,. The efficacy and safety of stent redilatation in congenital heart disease. Heart 2003; 89: 905-912.
8. Stanfill R, Nykanen DG, Osorio S, Whalen R, Burke RP, Zahn EM,. Stent implantation is effective treatment of vascular stenosis in young infants with congenital heart disease: acute implantation and long-term follow-up results. Catheter Cardiovasc Interv 2008; 71: 831-841.
9. Maglione J, Bergersen L, Lock JE, McElhinney DB,. Ultra-high-pressure balloon angioplasty for treatment of resistant stenoses within or adjacent to previously implanted pulmonary arterial stents. Circ Cardiovasc Interv 2009; 2: 52-58.
10. Zanjani KS, Sabi T, Moysich A, Ovroutski S, Peters B, Miera O, Kuhne T, Nagdyman N, Berger F, Ewert P,. Feasibility and efficacy of stent redilatation in aortic coarctation. Catheter Cardiovasc Interv 2008; 72: 552-556.
11. Tomita H, Nakanishi T, Hamaoka K, Kobayashi T, Ono Y,. Stenting in congenital heart disease: medium- and long-term outcomes from the JPIC stent survey. Circ J 2010; 74: 1676-1683.
12. Ashwath R, Gruenstein D, Siwik E,. Percutaneous stent placement in children weighing less than 10 kilograms. Pediatr Cardiol 2008; 29: 562-567.
13. Stern HJ, Baird CW,. A premounted stent that can be implanted in infants and re-dilated to 20 mm: introducing the Edwards Valeo Lifestent. Catheter Cardiovasc Interv 2009; 74: 905-912.
14. ev3 (St Paul, MN) Intrastent large diameter biliary endoprosthesis site book.
15. Boston Scientific Corporation (Natick, MA) bench testing.
16. Aiyagari R., Extensive distortion and dysfunction of an Edwards Valeo Lifestent placed for stenosis of the superior vena cava. Catheter Cardiovasc Interv 2011; 78: 282-285.